» Phases of Clinical Trials

Phases of Clinical Trials

1960
Clinical trial setting with researchers discussing drug development processes in pharmacology.

Clinical trials for new drugs are conducted in a structured, multi-phase process. Phase I assesses safety and dosage in a small group of healthy volunteers. Phase II evaluates efficacy and side effects in a larger group of patients. Phase III confirms efficacy, monitors side effects, and compares it to standard treatments in a large patient population before regulatory submission.

The modern clinical trial system is a cornerstone of evidence-based medicine, designed to rigorously test the safety and efficacy of new therapeutic interventions before they are made widely available. The process begins after extensive preclinical research on animals and in vitro models suggests a compound is promising. Phase I trials are the first-in-human studies, typically involving 20-100 healthy volunteers. The primary goal is to determine the drug’s safety profile, including the safe dosage range and identifying acute side effects. Pharmacokinetics (how the body absorbs, distributes, metabolizes, and excretes the drug) is also a key focus. Phase II trials expand the study to several hundred patients who have the condition the drug is intended to treat. This phase aims to provide a preliminary assessment of the drug’s efficacy and to further evaluate its safety. Often, Phase II studies are randomized and include a placebo or standard treatment control group. Phase III trials are large-scale, pivotal studies involving several hundred to several thousand patients. These are typically multi-center, randomized, double-blind, controlled trials designed to provide the definitive evidence of the drug’s efficacy and safety required for regulatory approval. The data gathered in Phase III is used to compare the new drug against existing treatments or a placebo. If successful, the drug sponsor can file a New Drug Application (NDA) with regulatory bodies like the FDA. Phase IV, or post-marketing surveillance, occurs after the drug is approved and on the market. These studies monitor the drug’s long-term safety and effectiveness in a broad, diverse population, and can identify rare or long-term side effects not seen in the earlier, more controlled trials.

UNESCO Nomenclature: 3209
– Pharmacology

类型

Medical Procedure

Disruption

Foundational

使用方法

Widespread Use

Precursors

  • james lind’s 1747 scurvy trial, one of the first controlled clinical experiments
  • the nuremberg code (1947) establishing ethical principles for human experimentation
  • the declaration of helsinki (1964) providing ethical guidelines for medical research involving human subjects
  • the 1962 kefauver harris amendment to the fd&c act, requiring proof of efficacy

应用

  • development of all modern prescription drugs
  • approval process for vaccines
  • testing of new medical devices
  • post-market surveillance studies (phase iv)

专利:

Potential Innovations Ideas

级别需要会员

您必须是!!等级!!会员才能访问此内容。

立即加入

已经是会员? 在此登录
Related to: clinical trials, phase i, phase ii, phase iii, drug development, fda, efficacy, safety, pharmacology, new drug application.

发表回复

您的邮箱地址不会被公开。 必填项已用 * 标注

迎接新挑战
Mechanical Engineer, Project, Process Engineering or R&D Manager
有效的产品开发

可在短时间内接受新的挑战。
通过 LinkedIn 联系我
Plastic metal electronics integration, Design-to-cost, GMP, Ergonomics, Medium to high-volume devices & consumables, Lean Manufacturing, Regulated industries, CE & FDA, CAD, Solidworks, Lean Sigma Black Belt, medical ISO 13485

我们正在寻找新的赞助商

 

您的公司或机构从事技术、科学或研究吗?
> 给我们发送消息 <

接收所有新文章
免费,无垃圾邮件,电子邮件不分发也不转售

或者您可以免费获得完整会员资格以访问所有受限制的内容>这里<

Historical Context

(if date is unknown or not relevant, e.g. "fluid mechanics", a rounded estimation of its notable emergence is provided)

Related Invention, Innovation & Technical Principles

滚动至顶部

你可能还喜欢